{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/recent","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T19:42:42.219Z"},"count":24,"filters":{"office":"Division of Pharmaceutical Quality Operations IV"},"items":[{"id":"0a604b0b90113071","posted_date":"2024-08-13","letter_issue_date":"2024-07-10","company_name":"Central Admixture Pharmacy Services, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/0a604b0b90113071"},{"id":"9f06fb9df2e80cb1","posted_date":"2024-08-06","letter_issue_date":"2024-07-23","company_name":"Omega Tech Labs LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug","canonical_url":"https://api.morvs.ai/fda-warning/9f06fb9df2e80cb1"},{"id":"91d1a295751e3907","posted_date":"2024-07-23","letter_issue_date":"2024-07-01","company_name":"Genuine Virgin Aloe Corp dba Triderma","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/91d1a295751e3907"},{"id":"3d689959c198c5b6","posted_date":"2024-07-09","letter_issue_date":"2024-06-20","company_name":"Optikem International Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/3d689959c198c5b6"},{"id":"5417ba1ce68e4130","posted_date":"2024-05-21","letter_issue_date":"2024-03-25","company_name":"Central Admixture Pharmacy Services, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Drug Products/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/5417ba1ce68e4130"},{"id":"6590bc3c6d2d6e8e","posted_date":"2024-05-14","letter_issue_date":"2024-04-17","company_name":"Westwood Laboratories LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/6590bc3c6d2d6e8e"},{"id":"348dea40f98233aa","posted_date":"2024-05-14","letter_issue_date":"2024-04-15","company_name":"Cohere Beauty","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/348dea40f98233aa"},{"id":"d223ba139b185f9a","posted_date":"2023-12-26","letter_issue_date":"2023-12-05","company_name":"Colonial Dames Company, Ltd","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/d223ba139b185f9a"},{"id":"0d257bd1ecb9efae","posted_date":"2023-11-21","letter_issue_date":"2023-10-20","company_name":"Elemental Herbs Inc. d/b/a ALL good","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/0d257bd1ecb9efae"},{"id":"a50547e665420fb1","posted_date":"2023-08-29","letter_issue_date":"2023-08-03","company_name":"K.C. Pharmaceuticals Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/a50547e665420fb1"},{"id":"2616f11ae3f4bc23","posted_date":"2023-06-06","letter_issue_date":"2023-06-01","company_name":"Mr. Lulu LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/2616f11ae3f4bc23"},{"id":"1fac8a7081549a95","posted_date":"2023-03-28","letter_issue_date":"2023-03-13","company_name":"NuGeneration Technologies LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/1fac8a7081549a95"},{"id":"fb385653d86b8d9d","posted_date":"2023-03-21","letter_issue_date":"2023-03-10","company_name":"Cosmetic Science Laboratories LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/fb385653d86b8d9d"},{"id":"8c3287266037e44e","posted_date":"2023-03-14","letter_issue_date":"2023-03-01","company_name":"Formology Lab Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/8c3287266037e44e"},{"id":"cf6475302e9657fc","posted_date":"2023-02-28","letter_issue_date":"2022-12-20","company_name":"Ultra Chem Labs Corporation","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/cf6475302e9657fc"},{"id":"5ec94809c3b8072f","posted_date":"2023-01-17","letter_issue_date":"2022-12-13","company_name":"Optum Infusion Services 308 LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/5ec94809c3b8072f"},{"id":"d79171fb87635b15","posted_date":"2022-12-27","letter_issue_date":"2022-12-16","company_name":"Green Pharmaceuticals Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"Drug Product/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/d79171fb87635b15"},{"id":"d0703263404248ac","posted_date":"2022-09-13","letter_issue_date":"2022-09-01","company_name":"Virgin Scent Inc. dba Artnaturals","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/d0703263404248ac"},{"id":"a3cc2dee49f009d7","posted_date":"2022-01-25","letter_issue_date":"2021-12-29","company_name":"Health Plus Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/a3cc2dee49f009d7"},{"id":"5840a195fbfb0455","posted_date":"2021-12-14","letter_issue_date":"2021-11-29","company_name":"Sanitor Corporation","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/5840a195fbfb0455"},{"id":"b9f1034f182d5c8c","posted_date":"2021-11-23","letter_issue_date":"2021-09-24","company_name":"Chameleon Beverage Co. Inc. dba Chameleon Sanitizer Corporation","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/b9f1034f182d5c8c"},{"id":"19c9cb92c8b05751","posted_date":"2021-11-16","letter_issue_date":"2021-11-08","company_name":"Global Sanitizers LLC","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/19c9cb92c8b05751"},{"id":"3dcb11085d2eab3e","posted_date":"2021-11-09","letter_issue_date":"2021-08-17","company_name":"Adamson Analytical Laboratories, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/3dcb11085d2eab3e"},{"id":"c5950b7c16e4ac04","posted_date":"2021-04-27","letter_issue_date":"2021-04-15","company_name":"Joe Wise Pharmacy, Inc., dba Wise Pharmacy","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/c5950b7c16e4ac04"}]}